Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/OR/Salem
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Salem, OR

Studies commonly pay $75 to $4,500 per completed study

111 clinical trials are currently recruiting participants within 30 miles of Salem. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

111studies recruiting
6+research centers nearby
2condition categories
Live from the NIH registry

Studies recruiting near Salem right now

Top 25 of 111 recruiting studies, sorted by proximity — each links to its official registry page

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05879926)

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors

Gynecologic Cancers, Breast Cancer Phase 1 Interventional 60 participants sought
Samaritan Pastega Regional Cancer Center — Corvallis, Oregon (27.4 mi) · Sponsor: Oregon State University
See eligibility & contact on ClinicalTrials.gov (NCT07055854)

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04269902)

Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury

Acute Kidney Injury N/A Interventional 339 participants sought
Samaritan Health — Corvallis, Oregon (27.4 mi) · Sponsor: SeaStar Medical
See eligibility & contact on ClinicalTrials.gov (NCT05758077)

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer Phase 3 Interventional 750 participants sought
Oregon Oncology Specialists — Salem, Oregon (1.5 mi) · Sponsor: Amgen
See eligibility & contact on ClinicalTrials.gov (NCT07213674)

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Prostate Cancer (Adenocarcinoma) Phase 3 Interventional 830 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: Canadian Cancer Trials Group
See eligibility & contact on ClinicalTrials.gov (NCT06592924)

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Multiple conditions Phase 2 Interventional 120 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06649812)

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Colorectal Neoplasms Phase 3 Interventional 400 participants sought
Providence Cancer Institute Newberg Clinic — Newberg, Oregon (26.2 mi) · Sponsor: Seagen, a wholly owned subsidiary of Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT05253651)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Salem, Oregon (1.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos N/A Interventional 535 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07091617)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma Phase 3 Interventional 360 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05256225)

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Refractory Differentiated Thyroid Gland Carcinoma Phase 3 Interventional 264 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT06475989)

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Phase 3 Interventional 2,400 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05929768)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Salem Hospital — Salem, Oregon (1.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632327)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)

The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

Aortoiliac Occlusive Disease, Peripheral Arterial Disease N/A Interventional 244 participants sought
Providence Heart & Vascular Institute — Wilsonville, Oregon (28.7 mi) · Sponsor: W.L.Gore & Associates
See eligibility & contact on ClinicalTrials.gov (NCT05811364)

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

Sepsis, Acute Kidney Injury Phase 2 Interventional 124 participants sought
Research Site — Corvallis, Oregon (27.4 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07215702)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02523014)

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma Phase 2 Interventional 396 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05633615)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06498635)

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Phase 2 Interventional 26 participants sought
Providence Newberg Medical Center — Newberg, Oregon (26.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05647265)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

Non-squamous Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Salem, Oregon (1.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06627647)
Actively enrolling

Studies you may be able to join near Salem

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Salem

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

OSH Museum of Mental Health

★ 4.6
2600 Center St NE, Salem, OR 97301
(971) 599-1674
"Easy to follow lay out. Beautiful grounds"
— Shelly Marlow, 5★

Oregon Medical Research Center

★ 4.4
1750 S Harbor Way Unit 330, Portland, OR 97201
(503) 245-1525
"Fantastic start to finish. The Staff at OMRC were kind, professional, helpful, informative, and were the first healthcare providers to believe me and…"
— Amy Pettinger, 5★

The Corvallis Clinic - Clinical Research Center

★ 5.0
The Corvallis Clinic, Asbury Building, 3680 NW Samaritan Dr, Corvallis, OR 97330
(541) 766-2163

Legacy Research Institute

★ 4.4
1225 NE 2nd Ave, Portland, OR 97232
(503) 413-2491
"Safe place to get help, PES is a little uncomfortable but they get you a bed as fast as they can and the nurses are almost all nice"
— Lukas, 4★

Summit Research Network Oregon, Inc.

★ 4.6
2701 NW Vaughn St #350, Portland, OR 97210
(503) 279-8252
"The entire staff from the front dest to the lab lady's, doctors, and medical assistants are extremely compationate and friendly."
— Valerie Carter, 5★

Northwest Research Center

★ 5.0
6327 SE Milwaukie Ave, Portland, OR 97202
(503) 238-6233

Clinical trials in Salem: what's recruiting

The Salem area currently has 111 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Salem, the most active research areas are:

  • Cancer & Oncology19 studies
  • Liver & Kidney2 studies

Every listing shows the study phase, the recruiting site and its distance from Salem, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Salem

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Salem participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Salem?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Salem safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Salem?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Salem?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Salem.

Paid clinical trials near Salem

Other metros within reach

Portland, OR1,031 Vancouver, WA1,031 Eugene, OR144 Olympia, WA229 Tacoma, WA1,454 Medford, OR39 Bremerton, WA1,475 Seattle, WA1,503

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Salem Bladder Issues Due To Spinal Cord Injury in Salem All conditions

More of OR

Portland1,031 Eugene144 Medford39

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts